Mastereksamen: Kjetil Jørgensen

Combination Treatments to Overcome Fibroblast-Associated Resistance to BRAF Inhibitors in Malignant Melanoma Use of the PeggySue Technology to Explore Drug Responses at a Protein level

Veileder Lina Prasmickaite, OUS-DNR, Ola Myklebost, IBV

Sensorer: Anders Øverbye, OUS-DNR, Federico Fenaroli, IBV

Publisert 17. mars 2017 10:49 - Sist endret 17. mars 2017 13:39